Rick Jantz focuses on domestic and international transactional tax matters. He has advised public and private companies, private equity funds, financial institutions and non-profit organizations. 

Download full bio 


  • X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics 

  • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 

  • Vir Biotechnology - $143 Million IPO 

  • Arlo to Partner with Verisure 

  • Reata Pharmaceuticals – $505 Million Follow-On Offering 

  • View all


  • New York University School of Law
    JD, Jacobson Scholar, 2015

  • University of California, Los Angeles
    BA, Business Economics

Admissions & Credentials